OnKure Therapeutics Inc. - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: OnKure Therapeutics Inc. - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: OnKure Therapeutics Inc. - Ordinary Shares - Class A
Rating: 1.32283325
Author: Trendlyne DVM scores

about

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company op...

2.75 -0.06 (-2.14%)

85.82% Fall from 52W High

37,314

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for OnKure Therapeutics Inc. - Ordinary Shares - Class A is on 03 Sep 2025 for the purpose of Cantor Global Healthcare investor conference See details